1![Introduction ASTEX case results Sensitivity test Introduction ASTEX case results Sensitivity test](https://www.pdfsearch.io/img/f7bf13e2ffc08f8f46b3d73c21c3318f.jpg) | Add to Reading ListSource URL: www.euclipse.nlLanguage: English - Date: 2010-09-14 04:26:57
|
---|
2![Met office ASTEX simulations Adrian Lock, Met office, UK © Crown copyright Met Office
Contents Met office ASTEX simulations Adrian Lock, Met office, UK © Crown copyright Met Office
Contents](https://www.pdfsearch.io/img/b5f64eb2a09d4f41b5da39857aac1e08.jpg) | Add to Reading ListSource URL: www.euclipse.nlLanguage: English - Date: 2010-09-14 07:37:45
|
---|
3![Microsoft Word - Exkursion 9 _ AsteX GmbH Microsoft Word - Exkursion 9 _ AsteX GmbH](https://www.pdfsearch.io/img/9d5f3cdc05644059c9933c8bf38e7b22.jpg) | Add to Reading ListSource URL: www.get-it.tu-berlin.deLanguage: German - Date: 2010-02-12 09:02:46
|
---|
4![Professor Sir Tom L. Blundell, FRS, FMedSci A Biographical Sketch Professor Sir Tom Blundell is Professor Emeritus in the Department of Biochemistry at the University of Cambridge. Professor Blundell has been the Sir Wil Professor Sir Tom L. Blundell, FRS, FMedSci A Biographical Sketch Professor Sir Tom Blundell is Professor Emeritus in the Department of Biochemistry at the University of Cambridge. Professor Blundell has been the Sir Wil](https://www.pdfsearch.io/img/712bfb744e741b4a61ede79b7f90b2d3.jpg) | Add to Reading ListSource URL: www.biochem.hku.hkLanguage: English - Date: 2014-09-29 00:04:09
|
---|
5![Microsoft Word - D3.3_Detailed analyses of the LES and SCM results for ASTEX and the two GPCI columns.docx Microsoft Word - D3.3_Detailed analyses of the LES and SCM results for ASTEX and the two GPCI columns.docx](https://www.pdfsearch.io/img/338eef0f1c896815ea8dbd0c316e8fd3.jpg) | Add to Reading ListSource URL: www.euclipse.euLanguage: English - Date: 2013-01-31 07:40:15
|
---|
6![1A.3 LARGE-EDDY SIMULATION OF A STRATOCUMULUS TO CUMULUS CLOUD TRANSITION AS OBSERVED DURING ASTEX Stephan R. de ROODE∗ and Johan van der DUSSEN Multi-Scale Physics, Delft University of Technology, The Netherlands win 1A.3 LARGE-EDDY SIMULATION OF A STRATOCUMULUS TO CUMULUS CLOUD TRANSITION AS OBSERVED DURING ASTEX Stephan R. de ROODE∗ and Johan van der DUSSEN Multi-Scale Physics, Delft University of Technology, The Netherlands win](https://www.pdfsearch.io/img/6295a8140c8bc3384d3fb596a13ad9f7.jpg) | Add to Reading ListSource URL: ams.confex.comLanguage: English - Date: 2010-08-23 04:43:45
|
---|
7![Microsoft Word - D3.1 Description of the set-up for th ASTEX, the GPCI stratocumulus and shallow cumulus, and the SCM equilibri Microsoft Word - D3.1 Description of the set-up for th ASTEX, the GPCI stratocumulus and shallow cumulus, and the SCM equilibri](https://www.pdfsearch.io/img/2370ed0153ba16dd7f6a3ae59928232f.jpg) | Add to Reading ListSource URL: www.euclipse.euLanguage: English - Date: 2011-07-07 07:04:04
|
---|
8![July 20, 2012 DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq: July 20, 2012 DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:](https://www.pdfsearch.io/img/d6a16119211346fbe588639f2b8b1f1d.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
9![April 29, 2013 Astex Pharmaceuticals Reports 2013 First Quarter Financial Results Data reported at AACR on several preclinical and clinical programs Ends quarter with $137 million in cash & marketable securities First q April 29, 2013 Astex Pharmaceuticals Reports 2013 First Quarter Financial Results Data reported at AACR on several preclinical and clinical programs Ends quarter with $137 million in cash & marketable securities First q](https://www.pdfsearch.io/img/dc1bfaaceb09de9bc5af98fbc38f234c.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
10![September 10, 2012 Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq: September 10, 2012 Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:](https://www.pdfsearch.io/img/331b25ec2003c231793414f599744492.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|